Td Ameritrade Investment Management, LLC Sarepta Therapeutics, Inc. Transaction History

Td Ameritrade Investment Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$69.38 - $86.75 $416 - $520	-6 Closed	0 $0
Q4 2020 Feb 10, 2021	BUY	$125.56 - $178.74 $753 - $1,072	6 New	6 $1,000
Q3 2019 Nov 07, 2019	SELL	$72.81 - $156.91 $946 - $2,039	-13 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$106.67 - $151.68 $3,840 - $5,460	-36 Reduced 73.47%	13 $2,000
Q4 2018 Feb 13, 2019	BUY	$97.32 - $148.76 $3,016 - $4,611	31 Added 172.22%	49 $5,000
Q3 2018 Nov 14, 2018	BUY	$115.31 - $161.51 $345 - $484	3 Added 20.0%	18 $3,000
Q2 2018 Aug 10, 2018	BUY	$71.74 - $153.69 $1,076 - $2,305	15 New	15 $2,000

528

84M

2.06M

1.52M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $10.4B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Td Ameritrade Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Td Ameritrade Investment Management, LLC with notifications on news.